Skip to main content
Insight Molecular Diagnostics Inc. logo

Insight Molecular Diagnostics Inc. — Investor Relations & Filings

Ticker · IMDX ISIN · US68235C1071 LEI · 549300BIYAW8GO410287 US Human health and social work activities
Filings indexed 646 across all filing types
Latest filing 2026-04-30 Annual Report
Country US United States of America
Listing US IMDX

About Insight Molecular Diagnostics Inc.

https://imdxinc.com/

Insight Molecular Diagnostics Inc. (iMDx) is a precision diagnostics company that develops and commercializes molecular diagnostic tests. The company focuses on advancing precision medicine in transplantation and oncology. Its solutions are designed for researchers, clinicians, and healthcare systems to enable early detection, guide treatment, and accelerate discovery. Key products include blood-based tests for transplant monitoring that quantify donor-derived cell-free DNA (dd-cfDNA) to assess organ health following transplantation. In oncology, the company provides tools to support cancer immunotherapy guidance. iMDx aims to deliver accurate and scalable diagnostic tools that provide clear, actionable insights for clinical and research decision-making.

Recent filings

Filing Released Lang Actions
ARS - Insight Molecular Diagnostics Inc. (0001642380) (Filer)
Annual Report
2026-04-30 English
8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)
Regulatory Filings
2026-04-30 English
8-K - INSIGHT MOLECULAR DIAGNOSTICS INC. (0001642380) (Filer)
Regulatory Filings
2026-02-26 English
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-02-12 English
8-K Filing
Regulatory Filings
2026-02-12 English
4 Filing
Director's Dealing
2026-02-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.